Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

[1]  R. Grimm,et al.  Diffusion‐weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer , 2016, Journal of magnetic resonance imaging : JMRI.

[2]  A. Husain,et al.  Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  S. Singhal,et al.  Identification of breast cancer margins using intraoperative near‐infrared imaging , 2016, Journal of surgical oncology.

[4]  P. Low,et al.  Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins , 2016, Molecular Imaging and Biology.

[5]  Sunil Singhal,et al.  Intraoperative imaging identifies thymoma margins following neoadjuvant chemotherapy , 2015, Oncotarget.

[6]  D. Collins,et al.  Response evaluation in mesothelioma: Beyond RECIST. , 2015, Lung cancer.

[7]  B. Seifert,et al.  A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years’ Experience , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  S. Armato,et al.  Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group. , 2015, Lung cancer.

[9]  Shuming Nie,et al.  Intraoperative near-infrared fluorescence imaging and spectroscopy identifies residual tumor cells in wounds , 2015, Journal of biomedical optics.

[10]  S. Singhal,et al.  Identification of a subcentimeter pulmonary adenocarcinoma using intraoperative near-infrared imaging during video-assisted thoracoscopic surgery. , 2015, The Journal of thoracic and cardiovascular surgery.

[11]  Ping Li,et al.  Radiologic-pathologic correlation of mesothelioma tumor volume. , 2015, Lung cancer.

[12]  Samuel G Armato,et al.  Observer Variability in Mesothelioma Tumor Thickness Measurements: Defining Minimally Measurable Lesions , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  S. Armato,et al.  Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. , 2013, Lung cancer.

[14]  S. Armato,et al.  Disease volumes as a marker for patient response in malignant pleural mesothelioma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Samuel G Armato,et al.  Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  V. Goh,et al.  CT perfusion in oncologic imaging: a useful tool? , 2013, AJR. American journal of roentgenology.

[17]  F. Gleeson,et al.  Role of CT in assessing pleural malignancy prior to thoracoscopy , 2012, Thorax.

[18]  Shin Matsuoka,et al.  Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. , 2012, AJR. American journal of roentgenology.

[19]  V. Rusch,et al.  Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  S. Armato,et al.  Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Jae-Hun Kim,et al.  Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts , 2012, Korean journal of radiology.

[22]  C. Dooms,et al.  Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience. , 2012, Radiology.

[23]  D. Gandara,et al.  A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  Samuel G Armato,et al.  Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans. , 2011, Medical physics.

[25]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[26]  B. Seifert,et al.  Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? , 2011, European Respiratory Journal.

[27]  Samuel G Armato,et al.  Computerized segmentation and measurement of malignant pleural mesothelioma. , 2010, Medical physics.

[28]  S. Armato,et al.  Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. , 2010, Lung cancer.

[29]  Binsheng Zhao,et al.  Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  M. Okada,et al.  [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[31]  S. Armato,et al.  Current state and future directions of pleural mesothelioma imaging. , 2008, Lung cancer.

[32]  J. Thiran,et al.  Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  Samuel G Armato,et al.  Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. , 2006, Lung cancer.

[34]  Heber MacMahon,et al.  Variability in mesothelioma tumor response classification. , 2006, AJR. American journal of roentgenology.

[35]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[36]  Heber MacMahon,et al.  Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. , 2004, Medical physics.

[37]  M. Byrne,et al.  Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  K. Miles,et al.  Perfusion CT: a worthwhile enhancement? , 2003, The British journal of radiology.

[39]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[40]  E. van Marck,et al.  Angiogenic cytokines in mesothelioma: a study of VEGF, FGF‐1 and ‐2, and TGF β expression , 1999, The Journal of pathology.

[41]  C B Begg,et al.  Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. , 1999, AJR. American journal of roentgenology.

[42]  S. Steinberg,et al.  Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. , 1998, The Journal of thoracic and cardiovascular surgery.

[43]  T. Hada,et al.  Transforming growth factor‐beta 1 (TGF‐β1)‐ and β2‐like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer , 1994 .

[44]  E. Butchart,et al.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. , 1976, Thorax.

[45]  J. Jett.  State of the journal: 2011. , 2011, Journal of Thoracic Oncology.

[46]  G. Hillerdal.  Staging and evaluating responses in malignant pleural mesothelioma. , 2004, Lung cancer.

[47]  R. V. van Klaveren,et al.  Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. , 2004, Lung cancer.

[48]  K. Miles,et al.  Perfusion CT for the assessment of tumour vascularity: which protocol? , 2003, The British journal of radiology.

[49]  T. Hada,et al.  Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. , 1994, Clinical and experimental immunology.

[50]  R. Klocke,et al.  THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .

[51]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.